Alessandro De Carlo

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 16

Top Topics

Randomized Controlled Trial

Histone Deacetylase

Drug Administration

Top Venues

CPT: pharmacometrics & systems pharmacology

Clinical pharmacology and therapeutics

Journal of pharmacokinetics and pharmacodynamics

This page only lists publications with an associated author ORCID identifier.

Publications

Elena M Tosca, Alessandro De Carlo, Roberta Bartolucci, Francesco Fiorentini, Silvia Di Tollo, Maurizio Caserini, Maurizio Rocchetti, Paolo Bettica, Paolo Magni
In silico trial for the assessment of givinostat dose adjustment rules based on the management of key hematological parameters in polycythemia vera patients. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Alessandro De Carlo, Davide Ronchi, Marco Piastra, Elena Maria Tosca, Paolo Magni
Predicting ADMET Properties from Molecule SMILE: A Bottom-Up Approach Using Attention-Based Graph Neural Networks. Pharmaceutics 16 (6) (2024)
Elena Maria Tosca, Alessandro De Carlo, Davide Ronchi, Paolo Magni
Model-Informed Reinforcement Learning for Enabling Precision Dosing Via Adaptive Dosing. Clinical pharmacology and therapeutics (2024)
Alessandro De Carlo, Elena Maria Tosca, Martina Fantozzi, Paolo Magni
Reinforcement Learning and PK-PD Models Integration to Personalize the Adaptive Dosing Protocol of Erdafitinib in Patients with Metastatic Urothelial Carcinoma. Clinical pharmacology and therapeutics 115 (4) (2024)
Elena Maria Tosca, Alessandro De Carlo, Davide Ronchi, Paolo Magni
Model-Informed Reinforcement Learning for Enabling Precision Dosing Via Adaptive Dosing. Clinical pharmacology and therapeutics 116 (3) (2024)
Alessandro De Carlo, Elena Maria Tosca, Martina Fantozzi, Paolo Magni
Reinforcement Learning and PK-PD Models Integration to Personalize the Adaptive Dosing Protocol of Erdafitinib in Patients with Metastatic Urothelial Carcinoma. Clinical pharmacology and therapeutics (2024)
Elena M Tosca, Alessandro De Carlo, Roberta Bartolucci, Francesco Fiorentini, Silvia Di Tollo, Maurizio Caserini, Maurizio Rocchetti, Paolo Bettica, Paolo Magni
In silico trial for the assessment of givinostat dose adjustment rules based on the management of key hematological parameters in polycythemia vera patients. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Alessandro De Carlo, Davide Ronchi, Marco Piastra, Elena Maria Tosca, Paolo Magni
Predicting ADMET Properties from Molecule SMILE: A Bottom-Up Approach Using Attention-Based Graph Neural Networks. Pharmaceutics 16 (6) (2024)
Elena M Tosca, Alessandro De Carlo, Roberta Bartolucci, Francesco Fiorentini, Silvia Di Tollo, Maurizio Caserini, Maurizio Rocchetti, Paolo Bettica, Paolo Magni
In silico trial for the assessment of givinostat dose adjustment rules based on the management of key hematological parameters in polycythemia vera patients. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Alessandro De Carlo, Elena Maria Tosca, Martina Fantozzi, Paolo Magni
Reinforcement Learning and PK-PD Models Integration to Personalize the Adaptive Dosing Protocol of Erdafitinib in Patients with Metastatic Urothelial Carcinoma. Clinical pharmacology and therapeutics 115 (4) (2024)
Elena M Tosca, Alessandro De Carlo, Roberta Bartolucci, Francesco Fiorentini, Silvia Di Tollo, Maurizio Caserini, Maurizio Rocchetti, Paolo Bettica, Paolo Magni
In silico trial for the assessment of givinostat dose adjustment rules based on the management of key hematological parameters in polycythemia vera patients. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Elena M Tosca, Alessandro De Carlo, Roberta Bartolucci, Francesco Fiorentini, Silvia Di Tollo, Maurizio Caserini, Maurizio Rocchetti, Paolo Bettica, Paolo Magni
In silico trial for the assessment of givinostat dose adjustment rules based on the management of key hematological parameters in polycythemia vera patients. CPT: pharmacometrics & systems pharmacology (2024)
Alessandro De Carlo, Elena Maria Tosca, Martina Fantozzi, Paolo Magni
Reinforcement Learning and PK-PD Models Integration to Personalize the Adaptive Dosing Protocol of Erdafitinib in Patients with Metastatic Urothelial Carcinoma. Clinical pharmacology and therapeutics 115 (4) (2024)
Elena M Tosca, Alessandro De Carlo, Roberta Bartolucci, Francesco Fiorentini, Silvia Di Tollo, Maurizio Caserini, Maurizio Rocchetti, Paolo Bettica, Paolo Magni
In silico trial for the assessment of givinostat dose adjustment rules based on the management of key hematological parameters in polycythemia vera patients. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Elena M Tosca, Alessandro De Carlo, Roberta Bartolucci, Francesco Fiorentini, Silvia Di Tollo, Maurizio Caserini, Maurizio Rocchetti, Paolo Bettica, Paolo Magni
In silico trial for the assessment of givinostat dose adjustment rules based on the management of key hematological parameters in polycythemia vera patients. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Alessandro De Carlo, Elena Maria Tosca, Nicola Melillo, Paolo Magni
A two-stages global sensitivity analysis by using the δ sensitivity index in presence of correlated inputs: application on a tumor growth inhibition model based on the dynamic energy budget theory. Journal of pharmacokinetics and pharmacodynamics (2023)